Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.

@article{Vitale2015SurvivalBO,
  title={Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.},
  author={Alessandro Vitale and Patrizia Burra and Anna Chiara Frigo and Franco Trevisani and Fabio Farinati and Gaya Spolverato and Michael L. Volk and Edoardo Giovanni Giannini and Francesca Ciccarese and Fabio Piscaglia and Gian Lodovico Rapaccini and Mariella Di Marco and Eugenio Caturelli and Marco Zoli and Franco Borzio and Giuseppe Cabibbo and Martina Felder and Antonio Gasbarrini and Rodolfo Sacco and Francesco Giuseppe Foschi and Gabriele Missale and Filomena Morisco and Gianluca Svegliati Baroni and Roberto Virdone and Umberto Cillo},
  journal={Journal of hepatology},
  year={2015},
  volume={62 3},
  pages={617-24}
}
BACKGROUND & AIMS The role of hepatic resection for hepatocellular carcinoma (HCC) in different Barcelona Clinic Liver Cancer (BCLC) stages is controversial. We aimed at measuring the survival benefit of resection vs. non-surgical-therapies in each BCLC stage. METHODS Using the ITA.LI.CA database, we identified 2090 BCLC A, B, and C HCC patients observed… CONTINUE READING